Medical Research Grants: leukodystrophies and myelin repair

ELA International wishes to focus funding on studies aimed at understanding disease mechanisms, developing natural history studies including outcome measures and biomarkers, and conducting clinical trials that focus on unmet needs in the leukodystrophy field.

Research Topics of Interest include :

• Clinical trial / clinical trial readiness including the development of longitudinal outcome measures, biomarker characterization, imaging modalities and pharmacodynamics /pharmacokinetic studies.
• Preclinical studies specifically testing therapies (gene, cell, enzyme or pharmacologic therapies).
• Developing animal or cell-based models (e.g. patient derived iPSC) relevant to human leukodystrophy.
• Study of mechanisms responsible for disease, in order to identify new therapeutic approaches.
• Investigating the prevention and repair of white matter injury in humans or in specific leukodystrophy animal models.

Funding: €100,000 per year

Duration: 2 years 

Research Authority due date: 21.5.18